XML 58 R47.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity - Stock Awards (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
May 28, 2025
Jul. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Other disclosures            
Compensation expense     $ 150 $ 150 $ 480 $ 320
Restricted Stock            
Number of Other than Options            
Outstanding, beginning balance (in shares)         35,333  
Granted (in shares)         113,901  
Vested (in shares)         (92,401)  
Outstanding, ending balance (in shares)     56,833   56,833  
Weighted Average Exercise Price            
Outstanding, beginning balance (in dollars per share)         $ 34.8  
Granted (in dollars per share)         2.09  
Vested (in dollars per share)         1.96  
Outstanding, ending balance (in dollars per share)     $ 22.63   $ 22.63  
Other disclosures            
Compensation expense     $ 140 $ 130 $ 410 $ 260
Unrecognized compensation expense     $ 30   $ 30  
Weighted average period of recognition         8 months 4 days  
Restricted Stock | Non Management Directors            
Number of Other than Options            
Granted (in shares) 4,000          
Restricted Stock | Management            
Number of Other than Options            
Granted (in shares) 17,500          
Restricted Stock | Executive Officer            
Number of Other than Options            
Granted (in shares)         92,401  
Other disclosures            
Percentage of salary paid in stock   40.00%        
Restricted Stock | Vesting on April 1, 2026 | Non Management Directors            
Other disclosures            
Vesting rights (percentage per year) 50.00%          
Restricted Stock | Vesting on April 1, 2027 | Non Management Directors            
Other disclosures            
Vesting rights (percentage per year) 50.00%